ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
54.17
0.00
(0.00%)
Closed February 06 4:00PM
0.00
0.00
(0.00%)

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
54.17
Bid
-
Ask
-
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Market Cap
Previous Close
54.17
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
-
Shares Outstanding
1,550,163,000
Dividend Yield
-
PE Ratio
30.77
Earnings Per Share (EPS)
3.84
Revenue
45.81B
Net Profit
5.96B

About AstraZeneca PLC

A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from intern... A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its revenue. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Cambridge, Gbr
Founded
-

AZN Latest News

Targeting Cancer's Achilles Heel: AI-Driven DDR Therapies Offer Hope

Cancer, a complex disease characterized by uncontrolled cell growth and proliferation, is often rooted in defects within DNA repair mechanisms. Normally, cells possess intricate To read the full...

Biotech Shares Soar After AstraZeneca Stake & Research Collaboration

A Paris-based healthcare company saw an insanely bullish session on Wednesday after it was announced that AstraZeneca

EVUSHELD™  significantly protected against symptomatic COVID-19 for at least six months in PROVENT Phase III trial in high-risk populations

Pre-exposure prophylaxis (prevention) trial reduced risk of symptomatic COVID-19, with no severe disease or COVID-19-related deaths in EVUSHELD group Data published in the New England Journal of...

ULTOMIRIS® (ravulizumab-cwvz) demonstrated sustained improvements in functional activities and quality of life in adults with generalized myasthenia gravis through 60 weeks

Analysis of Phase III CHAMPION-MG trial open-label extension adds to growing body of safety and efficacy data for ULTOMIRIS in generalized myasthenia gravis Patients who transitioned from...

AstraZeneca Announces New Partnership with The National Fish and Wildlife Foundation to Plant One Million Trees

Partnership contributes to the AZ Forest global initiative to plant and maintain 50 million trees worldwide by the end of 2025 AstraZeneca has partnered with The National Fish and Wildlife...

EVUSHELD™ long-acting antibody combination retains neutralizing activity against Omicron variants including BA.2 in new independent studies

First in vivo data from Washington University show EVUSHELD reduces viral burden of all tested Omicron subvariants in the lungs New preclinical authentic ‘live’ virus data from Washington...

ENHERTU® (fam-trastuzumab deruxtecan-nxki) Significantly Improved Both Progression-Free and Overall Survival in DESTINY-Breast04 Trial in Patients with HER2-Low Metastatic Breast Cancer

First HER2-low metastatic breast cancer Phase III results for AstraZeneca and Daiichi Sankyo’s ENHERTU offer potential to redefine how the disease is classified and treated Positive high-level...

LYNPARZA® (olaparib) plus Abiraterone Reduced Risk of Disease Progression by 34% vs. Standard-of-Care in 1st-Line Metastatic Castration-Resistant Prostate Cancer

Combination was well tolerated and allowed patients to maintain their quality of life vs. patients treated with abiraterone alone PROpel Phase III trial results show clinically meaningful...

Eplontersen granted Orphan Drug Designation in the US for transthyretin amyloidosis

Eplontersen has been granted Orphan Drug Designation (ODD) in the US by the Food and Drug Administration (FDA) for the treatment of transthyretin-mediated amyloidosis, a systemic, progressive and...

IMFINZI® (durvalumab) Plus Tremelimumab Demonstrated Unprecedented Survival in 1st-line Unresectable Liver Cancer With 31% of Patients Alive at Three Years

A single priming dose of tremelimumab plus IMFINZI every four weeks reduced risk of death by 22% in HIMALAYA Phase III trial Combination also showed no increase in severe liver toxicity and...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DR
40000000DR
120000000DR
260000000DR
520000000DR
1560000000DR
2600000000DR

AZN - Frequently Asked Questions (FAQ)

What is the current AstraZeneca share price?
The current share price of AstraZeneca is $ 54.17
How many AstraZeneca shares are in issue?
AstraZeneca has 1,550,163,000 shares in issue
What is the market cap of AstraZeneca?
The market capitalisation of AstraZeneca is USD 83.97B
What is the 1 year trading range for AstraZeneca share price?
AstraZeneca has traded in the range of $ 0.00 to $ 0.00 during the past year
What is the PE ratio of AstraZeneca?
The price to earnings ratio of AstraZeneca is 30.77
What is the cash to sales ratio of AstraZeneca?
The cash to sales ratio of AstraZeneca is 4
What is the reporting currency for AstraZeneca?
AstraZeneca reports financial results in USD
What is the latest annual turnover for AstraZeneca?
The latest annual turnover of AstraZeneca is USD 45.81B
What is the latest annual profit for AstraZeneca?
The latest annual profit of AstraZeneca is USD 5.96B
What is the registered address of AstraZeneca?
The registered address for AstraZeneca is 1 FRANCIS CRICK AVENUE, CAMBRIDGE BIOMEDICAL CAMPUS, CAMBRIDGE, CB2 0AA
What is the AstraZeneca website address?
The website address for AstraZeneca is www.astrazeneca.com
Which industry sector does AstraZeneca operate in?
AstraZeneca operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AMPSAltus Power Inc
$ 4.87
(27.15%)
55.43M
TUYATuya Inc
$ 3.395
(25.74%)
8.68M
HKDAmtd Digital Inc
$ 3.175
(19.81%)
5.36M
SESSES AI Corporation
$ 1.315
(18.47%)
33.78M
PSFEPaysafe Limited
$ 23.06
(16.41%)
1.68M
WEXWEX Inc
$ 151.86
(-18.70%)
2.23M
HIIHuntington Ingalls Industries Inc
$ 159.74
(-18.32%)
2.39M
DNAGinkgo Bioworks Holdings Inc
$ 13.65
(-16.56%)
3.92M
HPHelmerich and Payne Inc
$ 27.72
(-16.48%)
8M
LSPDLightspeed Commerce Inc
$ 12.62
(-12.97%)
3.79M
FFord Motor Company
$ 9.265
(-7.44%)
223.02M
BBAIBigBear ai Holdings Inc
$ 6.77
(-4.78%)
165.87M
QBTSD Wave Quantum Inc
$ 5.975
(-4.55%)
57.79M
AMPSAltus Power Inc
$ 4.87
(27.15%)
55.43M
BBDBanco Bradesco SA
$ 2.229
(2.25%)
53.17M

Discussion

View Full Feed
MrMike241 MrMike241 3 minutes ago
A jammy yolk can be good if eating the egg hot, such as for breakfast with toast, or in a Raman.

Perfectly cooked through but not overcooked yolk is also delicious hot or cold. When cold, and in potato salad, cooked through is the only way to go.

My steam egg cooker is
Genz2 Genz2 3 minutes ago
https://www.nist.gov/system/files/documents/2017/06/05/040813_wave_systems_response_part2.pdf

Shouldn’t Wave already be a lock-in for this contract?! Can the Army continue to await not having Wave?? Do we really have to wait for comments until March 5th and not award Wave a contract
thecrusher2011 thecrusher2011 3 minutes ago
Yes your honor the guy in the red hat that's the one that stole all my money.

https://investorshub.advfn.com/uimage/uploads/2025/2/6/twyubScreenshot_20250206-225212.png
karlacorn3 karlacorn3 4 minutes ago
https://investorshub.advfn.com/uimage/uploads/2025/2/6/lownjSmall_251-2511514_ear-icon-transparent-listen-icon-hd-png-download.png
K
ITUP
FOFreddie FOFreddie 4 minutes ago
Dr Susan Wachter on impact from privatization

See 37:30 for about a very intelligent 5 minute conversation. POTUS 47 went to Wharton -

https://knowledge.wharton.upenn.edu/policies-that-work-series/
FNMA
flipper44 flipper44 4 minutes ago
Yeppa.
NWBO
Monterey2000 Monterey2000 5 minutes ago
I was thinking about JimLur today as well. Certainly would also be great if Loophole and others were still among us to celebrate with us.

Congrats to all longs who persevered with their IDCC investment all those years to finally be rewarded in stock price and now with an increased d
IDCC
vdog1776 vdog1776 5 minutes ago
WRONG!!!! They made a change that was the l exact question I asked!! They had said while some companies would have more time all OTC has till June of this year I believe! But then again you knew this already!

It’s called OTCQB I believe!
VXIT
Monterey2000 Monterey2000 5 minutes ago
I was thinking about JimLur today as well. Certainly would also be great if Loophole and others were still among us to celebrate with us.

Congrats to all longs who persevered with their IDCC investment all those years to finally be rewarded in stock price and now increased dividend.
IDCC
meirluc meirluc 5 minutes ago
Norisk, I realize that this poster has been super critical of NWBO
management and had claimed without evidence that after approval
the company was going to be bought and also underestimated the
considerable strides accomplished with the EDEN vaccine manufacturing
syst
NWBO
StonkMaster StonkMaster 5 minutes ago
To be honest, as you mentioned, the MHRA correspondence to Muee88 reads in a whole new light if you consider that inspections, or any related issues, were recently concluded at the time of the email.
NWBO
Uncleteddy Uncleteddy 6 minutes ago
https://x.com/secduffy/status/1887558301908426900?s=46&t=07aH4Lwy7jnl_oIXcE5Fyw

Hopefully we get the permits before he gets Clintoned 
TGLO
Jerkburger Jerkburger 7 minutes ago
A little DD. Southern glazers, is also souther wine and spirits owned by Wayne Chaplin. Southern Glazer's Wine and Spirits, LLC is the largest wine and spirits distributor in the United States with operations in 44 states and Washington, D.C.[3] Its portfolio is 45% wine and 55% spirits. It was the
HADV
Jack-Squatt Jack-Squatt 7 minutes ago
How long before Tonix drops below one dollar? To be then followed by another R/S! Tonix is run by a group of incompetent morons.
TNXP
thecrusher2011 thecrusher2011 7 minutes ago
He's the guy that needed a pardon because he told China that he would be on their side if Trump ever did anything. That is the textbook definition of treason.
Alexulf Alexulf 8 minutes ago
2025 Brixton Metals Year? See the facts presented:
https://investorshub.advfn.com/Brixton-Metals-Corp-BBBXF-31124
BBBXF
price_and_volume price_and_volume 8 minutes ago
Fugly chart. Never-ending bullish-pump into oblivion. Rinse, repeat.
...degenerate gamblers :( You've come up w/ a great IHUB advertising slogan!
HMBL
x993231 x993231 8 minutes ago
None that I know of, and there were never a million.

X
LWLG
Dallas-Cowboys Dallas-Cowboys 8 minutes ago
I looked through the earnings transcripts of the hyper scalers both commentary and QA, not a mention of Blackwell. I was disappointed hoping to get a feeling of Blackwell sell through. 
NVDA
Whalatane Whalatane 9 minutes ago
Sorry but these small trials are IMHO a total waste of time
This trial has an open-label treatment arm with Icosapent Ethyl (IPE) and a usual care arm. 50 participants will be randomised to IPE plus usual care, and 50 will be randomised to usual care only.
If they think they are going
AMRN
BDEZ BDEZ 9 minutes ago
Newsom Announces Properties Affected By Wildfires Will Be Seized By CA Dums and Used For Climate Change Inclusive Affordable Low Income Housing
ergo sum ergo sum 10 minutes ago
I was tempted to log on to X today to follow Liz Cheney.
StonkMaster StonkMaster 10 minutes ago
Luckily, March isn't that far away. I hope this is it this time.
NWBO
stockprofitter stockprofitter 11 minutes ago
Bessent said we ARE NEXT UPPPP
FNMA
BDEZ BDEZ 13 minutes ago
USAID funded Yellowstone